266,785 results on '"parkinson’s disease"'
Search Results
2. Microglia-derived exosomal ciRS-7 mediates IL-17A effect of promoting neurodegeneration via miR-7 and SNCA targets in an experimental Parkinson’s disease
3. Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease
4. Increased α-synuclein phosphorylation and oligomerization and altered enzymes in plasma of patients with Parkinson’s disease
5. Glycolytic pathways: The hidden regulators in Parkinson's disease
6. A single-cell transcriptome analysis reveals astrocyte heterogeneity and identifies CHI3L1 as a diagnostic biomarker in Parkinson's disease
7. Deciphering the role of neuropeptides as biomarkers for early diagnosis of Parkinson's disease
8. Does age, sex, and area of substantia nigra echogenicity predict the MRI appearance of nigrosome-1?
9. “Nattokinase as a potential therapeutic agent for preventing blood-brain barrier dysfunction in neurodegenerative disorders”
10. Novel Nose-to-brain delivery of carbenoxolone via mucoadhesive solid lipid nanoparticles for Parkinson’s symptoms management: In vitro and in vivo evaluation in a rotenone-induced rat model
11. In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models
12. Exploring the therapeutic potential of Chinese herbs on comorbid type 2 diabetes mellitus and Parkinson's disease: A mechanistic study
13. Revealing rutaecarpine’s promise: A pathway to parkinson’s disease relief through PPAR modulation
14. Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
15. Diffusion Kurtosis Imaging in Diagnosing Parkinson's Disease: A Preliminary Comparison Study Between Kurtosis Metric and Radiomic Features
16. Increased incidence of akinetic crises in Parkinson’s disease patients treated with Levodopa-Carbidopa Intestinal Gel: A case series and review of the literature
17. Differential gait features across Parkinson's disease clinical subtypes
18. Impulse control in Parkinson’s disease: Distinct effects between action and choice
19. A novel electrochemical sensor based on collaborative performance enhancement of hybrid Acid Orange 10 polymer/Zirconium nanoparticles for first voltammetric determination of Istradefylline in plasma
20. Association between Mediterranean diet adherence and Parkinson's disease: a systematic review and meta-analysis
21. From onset to advancement: the temporal spectrum of α-synuclein in synucleinopathies
22. Genetic and neurochemical profiles underlying cortical morphometric vulnerability to Parkinson’s disease
23. An update on drug repurposing in Parkinson’s disease: Preclinical and clinical considerations
24. Neuroprotective effects of gastrodin in both in vivo and in vitro models of Parkinson's disease: Mechanisms from the perspective of oxidative stress, ferroptosis, and cellular senescence
25. Incomplete multi-view feature selection with adaptive consensus graph constraint for Parkinson's disease diagnosis
26. The emerging role of oxygen redox in pathological progression of disorders
27. Plexins: Navigating through the neural regulation and brain pathology
28. Current trends in blood biomarkers detection and neuroimaging for Parkinson's disease
29. Is rapid eye movement sleep behavior disorder a marker of Parkinson's disease severity?
30. Simultaneous 5-HT1BR agonist/5-HT6R antagonist action as a potential treatment of Parkinson’s disease and its comorbidities
31. Drug repositioning for Parkinson’s disease: An emphasis on artificial intelligence approaches
32. Autophagic signatures in peripheral blood mononuclear cells from Parkinson's disease patients
33. Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis
34. Are impulsive compulsive behaviors associated with levodopa-induced dyskinesia? A Brazilian cross-sectional study
35. Ergothioneine exerts neuroprotective effects in Parkinson’s disease: Targeting α-synuclein aggregation and oxidative stress
36. Deep cervical lymphovenous bypass for Parkinson’s disease: A hypothesis
37. Duration of “Good On” time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®)
38. Exploring ocular disorders in Parkinson's disease: A comprehensive review and future perspectives
39. Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
40. Are you tuned in to others' mind? A cross-modal evaluation of affective theory of mind in people with Parkinson's disease
41. Computer model for gait assessments in Parkinson's patients using a fuzzy inference model and inertial sensors
42. Association between vestibular evoked myogenic potentials and different dizziness status in Parkinson's disease: A controlled study
43. Evaluating prognostic factors for falls in Parkinson's disease: A sex-based analysis
44. Co-stimulating the left vmPFC compensates for apathy after levodopa withdrawal in Parkinson's patients with STN DBS.
45. A pilot study for speech assessment to detect the severity of Parkinson’s disease: An ensemble approach
46. Inferring when to move
47. Sleep spindle variation in patients with Parkinson’s disease on first nights of sub-optimal deep brain stimulation
48. HDAC6 inhibitor-loaded brain-targeted nanocarrier-mediated neuroprotection in methamphetamine-driven Parkinson's disease
49. Regional cerebral cholinergic vesicular transporter correlates of visual contrast sensitivity in Parkinson's disease: Implications for visual and cognitive function
50. Etched Co[sbnd]Fe Prussian blue analog nanozymes with superior peroxidase activity for colorimetric biosensing of hydrogen peroxide and dopamine
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.